Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) has 9 years of Exchange Rate Effect data on file, last reported at -$2.4 million in Q2 2026.

• Quarterly Exchange Rate Effect fell 108.89% year-over-year to -$2.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$16.1 million (down 140.97% YoY) and the FY2025 annual result came in at $34.9 million, up 329.25% from the prior year.
• Exchange Rate Effect improved to -$2.4 million in Q2 2026, from -$7.1 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $27.5 million in Q2 2025 to a low of -$17.3 million in Q4 2024.
• A 5-year average of $508277.8 and a median of -$1.6 million in 2022 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2024 — Exchange Rate Effect tumbled 2300.0% — and 2025, when it soared 981.6%.
• Tracing ALNY's Exchange Rate Effect over 5 years: stood at $1.6 million in 2022, then surged by 573.07% to $10.9 million in 2023, then slumped by 258.49% to -$17.3 million in 2024, then jumped by 66.99% to -$5.7 million in 2025, then surged by 57.11% to -$2.4 million in 2026.
• The last three Exchange Rate Effect figures came in at -$2.4 million (Q2 2026), -$7.1 million (Q1 2026), and -$5.7 million (Q4 2025), per Business Quant data.